Zhang Yuanchun, Li Jing, Zhan Yuliang, Wu Lianqiu, Yu Xueying, Zhang Wenjian, Ye Liya, Xu Shiqing, Sun Ruihua, Wang Yunting, Lou Jinning
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, People's Republic of China.
Infect Immun. 2004 Aug;72(8):4410-5. doi: 10.1128/IAI.72.8.4410-4415.2004.
Severe acute respiratory syndrome (SARS) is an acute infectious disease of the respiratory system. Although a novel coronavirus has been identified as the causative agent of SARS, the pathogenic mechanisms of SARS are not understood. In this study, sera were collected from healthy donors, patients with SARS, patients with severe SARS, and patients with SARS in convalescence. The serum concentrations of interleukin-1 (IL-1), IL-4, IL-6, IL-8, IL-10, tumor growth factor beta (TGF-beta), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were measured by enzyme-linked immunosorbent assays (ELISA). The concentrations of IL-1 and TNF-alpha were not significantly different in different groups. The IL-6 concentration was increased in SARS patients and was significantly elevated in severe SARS patients, but the IL-6 concentrations were similar in convalescent patients and control subjects, suggesting that there was a positive relationship between the serum IL-6 concentration and SARS severity. The concentrations of IL-8 and TGF-beta were decreased in SARS patients and significantly reduced in severe SARS patients, but they were comparable in convalescent SARS patients and control subjects, suggesting that there was a negative relationship between the IL-8 and TGF-beta concentrations and SARS severity. The concentrations of IFN-gamma, IL-4, and IL-10 showed significant changes only in convalescent SARS patients. The IFN-gamma and IL-4 levels were decreased, while the levels of IL-10 were increased, and the differences between convalescent SARS patients and other patient groups were statistically significant. These results suggest that there are different immunoregulatory events during and after SARS and may contribute to our understanding of the pathogenesis of this syndrome.
严重急性呼吸综合征(SARS)是一种急性呼吸系统传染病。尽管一种新型冠状病毒已被确定为SARS的病原体,但SARS的致病机制尚不清楚。在本研究中,收集了健康供体、SARS患者、重症SARS患者以及SARS恢复期患者的血清。通过酶联免疫吸附测定(ELISA)检测白细胞介素-1(IL-1)、IL-4、IL-6、IL-8、IL-10、肿瘤生长因子β(TGF-β)、肿瘤坏死因子α(TNF-α)和γ干扰素(IFN-γ)的血清浓度。不同组中IL-1和TNF-α的浓度无显著差异。SARS患者的IL-6浓度升高,重症SARS患者中显著升高,但恢复期患者和对照受试者的IL-6浓度相似,这表明血清IL-6浓度与SARS严重程度呈正相关。SARS患者中IL-8和TGF-β的浓度降低,重症SARS患者中显著降低,但恢复期SARS患者和对照受试者的浓度相当,这表明IL-8和TGF-β浓度与SARS严重程度呈负相关。IFN-γ、IL-4和IL-10的浓度仅在SARS恢复期患者中出现显著变化。IFN-γ和IL-4水平降低,而IL-10水平升高,SARS恢复期患者与其他患者组之间的差异具有统计学意义。这些结果表明,SARS期间和之后存在不同的免疫调节事件,可能有助于我们理解该综合征的发病机制。